DNA RNA and Cells

22 Feb 2010 Histostem Participates in Clinical Trials Demonstrating the Effective Use of Its Proprietary Stem Cells in the Treatment of Cirrhosis of the Liver
22 Feb 2010 Alnylam Initiates Phase IIb Clinical Trial of ALN-RSV01 in Adult Lung Transplant Patients Infected with Respiratory Syncytial Virus (RSV) Infection
18 Feb 2010 Dynavax and GlaxoSmithKline Select Clinical Candidate in the Endosomal TLR Inhibitor Program
16 Feb 2010 Athersys Announces Completion of Patient Enrollment in Phase I Study of Multistem(R) in Acute Myocardial Infarction
16 Feb 2010 Oncolytics Biotech(R) Inc. Receives Approval from the U.K. MHRA to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
14 Feb 2010 Idera Pharmaceuticals Presents Preclinical Hyperlipidemia Data on a Toll-like Receptor Antagonist at Keystone Symposium
10 Feb 2010 Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma
10 Feb 2010 ReNeuron receives final regulatory approval to commence landmark stroke clinical trial in UK
10 Feb 2010 StemCells, Inc. Announces First Human Neural Stem Cell Transplant in Landmark Myelination Disorder Trial
10 Feb 2010 Mipomersen Phase 3 Study in Patients with Heterozygous Familial Hypercholesterolemia Meets Primary Endpoint
04 Feb 2010 Bioheart Launches First US FDA Approved Clinical Trial that Tests Gene-Modified Stem Cell Therapy in Patients with Congestive Heart Failure
04 Feb 2010 AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophy Published in the International Journal of Toxicology
03 Feb 2010 Data on ATL1101 Prostate Tumour Suppression Published in Scientific Journal & Australian Patent Granted
02 Feb 2010 California Stem Cell and ALS Therapy Development Institute Extend Their Collaboration to Advance Potential Stem Cell Assisted Therapy for ALS
01 Feb 2010 Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
29 Jan 2010 CellProthera achieves a revolutionary breakthrough in the treatment of myocardial infarction with the support of the Alsace Region and the Alsace BioValley biocluster
28 Jan 2010 First Refractory Angina Patient treated with VEGF-D shortform (EG011) in Phase I/IIa trial
28 Jan 2010 Regulatory Update
28 Jan 2010 Idera Pharmaceuticals Initiates Phase 1 Clinical Trial of IMO-3100, a Toll-like Receptor Antagonist Intended for Autoimmune Disease Indications
27 Jan 2010 ALS Therapy Development Institute and Oxford BioMedica Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
26 Jan 2010 Geron Forms Collaboration to Investigate GRNOPC1 in Alzheimer's Disease Models
26 Jan 2010 Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infection
26 Jan 2010 Cardium Provides Update on Commercial Development Plans for Generx Angiogenic Therapy for Heart Disease at 2010 Cell & Gene Therapy Forum
25 Jan 2010 Osiris Completes Enrollment in Stem Cell Trial for Type 1 Diabetes

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up